(Q37364079)

19 August 2017

Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors (English)

1 reference

19 August 2017

0 references

Radharani Gollamudi

1

1 reference

19 August 2017

Mohammad H Ghalib

2

1 reference

19 August 2017

Kavita K Desai

3

1 reference

19 August 2017

Imran Chaudhary

4

1 reference

19 August 2017

Benny Wong

5

1 reference

19 August 2017

Mark Einstein

6

1 reference

19 August 2017

Matthew Coffey

7

1 reference

19 August 2017

George M Gill

8

1 reference

19 August 2017

Karl Mettinger

9

1 reference

19 August 2017

John M Mariadason

10

1 reference

19 August 2017

Sridhar Mani

11

1 reference

19 August 2017

Sanjay Goel

12

1 reference

19 August 2017

language of work or name

1 reference

2 July 2009

1 reference

Investigational New Drugs

19 August 2017

1 reference

19 August 2017

28

1 reference

19 August 2017

5

1 reference

19 August 2017

641-649

1 reference

https://scigraph.springernature.com/pub.10.1007/s10637-009-9279-8

19 August 2017

0 references

cites work

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Reovirus therapy of tumors with activated Ras pathway

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Viruses in the treatment of cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

ras oncogenes in human cancer: a review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Oncolytic viral therapy for human pancreatic cancer cells by reovirus.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Viruses causing common respiratory infection in man. IV. Reoviruses and Adenoviruses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Oncolytic reovirus against ovarian and colon cancer.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

High frequency of N-ras activation in acute myelogenous leukemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

China approves world's first oncolytic virus therapy for cancer treatment

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Reovirus infections in human volunteers.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Reovirus therapy of lymphoid malignancies.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Reovirus oncolysis of human breast cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Phase I clinical trial design in cancer drug development

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851036

Systemic reovirus therapy of metastatic cancer in immune-competent mice

2 September 2018

1 reference

12 December 2020

Prevalence of ras gene mutations in human colorectal cancers

1 reference

12 December 2020

Activated ras oncogenes in human thyroid cancers

1 reference

12 December 2020

High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas

1 reference

12 December 2020

A study of human reovirus IgG and IgA antibodies by ELISA and western blot

1 reference

12 December 2020

Serologic grouping of reoviruses by hemagglutination-inhibition

1 reference

12 December 2020

Reoviruses. A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described

1 reference

12 December 2020

10.1007/S10637-009-9279-8

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19572105

1 reference